[Federal Register Volume 67, Number 205 (Wednesday, October 23, 2002)]
[Notices]
[Page 65130]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-26875]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 02N-0012]


Agency Information Collection Activities; Announcement of OMB 
Approval; Postmarketing Adverse Drug Experience Reporting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Postmarketing Adverse Drug 
Experience Reporting'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Information 
Resources Management (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-1482.

SUPPLEMENTARY INFORMATION: In the Federal Register of July 22, 2002 (67 
FR 47821), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0230. 
The approval expires on September 30, 2005. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: October 16, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-26875 Filed 10-22-02; 8:45 am]
BILLING CODE 4160-01-S